Correction: Castanea sativa (European Chestnut) leaf extracts rich in ursene and oleanene derivatives block staphylococcus aureus virulence and pathogenesis without detectable resistance (PLoS ONE (2015) 10:8 (e0136486) DOI: 10.1371/journal.pone.0136486);Castanea sativa (European Chestnut) leaf extracts rich in ursene and oleanene derivatives block Staphylococcus aureus virulence and pathogenesis without detectable resistance

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Quave, Cassandra L ^a,b   Lyles, James T ^a   Kavanaugh, Jeffery S ^c   Nelson, Kate ^b   Parlet, Corey P ^c   Crosby, Heidi A ^c   Heilmann, Kristopher P ^c   Horswill, Alexander R ^c  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; AMPICILLIN; ANTIINFECTIVE AGENT; BACTERIAL TOXIN; BUTANOL; CASTANEA SATIVA EXTRACT; DELTA TOXIN; HEXANE; KANAMYCIN; OLEANENE DERIVATIVE; PLANT EXTRACT; STAUROSPORINE; STREPTOMYCIN; TRITERPENE; UNCLASSIFIED DRUG; URSENE DERIVATIVE; WATER; AGR PROTEIN, STAPHYLOCOCCUS AUREUS; BACTERIAL PROTEIN; HEMOLYSIN; OLEANOLIC ACID; STAPHYLOCOCCAL ALPHA-TOXIN; STAPHYLOCOCCAL DELTA TOXIN; TRANSACTIVATOR PROTEIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; CASTANEA SATIVA; CHEMICAL COMPOSITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG RESISTANCE; DRUG STRUCTURE; ETHNOBOTANY; FEMALE; HEMOLYSIS; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PLANT LEAF; QUORUM SENSING INHIBITION; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBIOTIC RESISTANCE; BIOSYNTHESIS; CELL CULTURE; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ERYTHROCYTE; FAGACEAE; GENETICS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; QUORUM SENSING; RABBIT; STAPHYLOCOCCAL SKIN INFECTIONS; VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TOXINS; CELL LINE; CELLS, CULTURED; DRUG RESISTANCE, BACTERIAL; ERYTHROCYTES; FAGACEAE; HEMOLYSIN PROTEINS; HUMANS; KERATINOCYTES; MICE; MICROBIAL SENSITIVITY TESTS; OLEANOLIC ACID; PLANT EXTRACTS; PLANT LEAVES; QUORUM SENSING; RABBITS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS; VIRULENCE;

EID: 84942915722     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0163655     Document Type: Erratum

References (69)

1. CDC. Antibiotic resistance threats in the United States, 2013. Atlanta, GA: Centers for Disease Control, 2013.
2. Ross-Gillespie A, Kümmerli R. Collective decision-making in microbes. Front Microbiol. 2014;5. doi: 10. 3389/fmicb.2014.00054
3. Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, et al. A new antibiotic kills pathogens without detectable resistance. Nature. 2015;517 (455-459). doi: 10.1038/nature14098
4. Quave CL, Plano LRW, Bennett BC. Quorum sensing inhibitors of Staphylococcus aureus from Italian medicinal plants. Planta Med. 2011;77(02):188-95. doi: 10.1055/s-0030-1250145
5. Quave C, Plano L, Pantuso T, Bennett B. Effects of extracts from Italian medicinal plants on planktonic growth, biofilm formation and adherence of methicillin-resistant Staphylococcus aureus. J Ethnopharmacol. 2008;118(3):418-28. doi: 10.1016/j.jep. 2008.05.005 PMID: 18556162
6. Quave CL, Estévez-Carmona M, Compadre CM, Hobby G, Hendrickson H, Beenken KE, et al. Ellagic acid derivatives from Rubus ulmifolius inhibit Staphylococcus aureus biofilm formation and improve response to antibiotics. PLoS One. 2012;7(1):e28737. doi: 10.1371/journal.pone.0028737 PMID: 22242149
7. Pieroni A, Quave CL, Villanelli ML, Mangino P, Sabbatini G, Santini L, et al. Ethnopharmacognostic survey on the natural ingredients used in folk cosmetics, cosmeceuticals and remedies for healing skin diseases in the inland Marches, Central-Eastern Italy. J Ethnopharmacol. 2004;91(2-3):331-44. doi: 10. 1016/j.jep. 2004.01.015 PMID: 15120458
8. Kluytmans J, Van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10(3):505-20. PMID: 9227864
9. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol. 2003;48(6):1429-49. PMID: 12791129
10. Tsuji BT, Rybak MJ, Cheung CM, Amjad M, Kaatz GW. Community- and health care-associated methicillinresistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis. 2007;58(1):41-7. PMID: 17300912
11. Otto M. Staphylococcus aureus toxins. Curr Opin Microbiol. 2014;17(0):32-7. doi: 10.1016/j.mib.2013. 11.004
12. Foster TJ, Geoghegan JA, Ganesh VK, Hook M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol. 2014;12(1):49-62. doi: 10.1038/nrmicro3161 PMID: 24336184
13. Spaan AN, Surewaard BGJ, Nijland R, Van Strijp JAG. Neutrophils versus Staphylococcus aureus: A biological tug of war. Annu Rev Microbiol. 2013;67(1):629-50. doi: 10.1146/annurev-micro-092412-155746
14. Thoendel M, Kavanaugh JS, Flack CE, Horswill AR. Peptide signaling in the staphylococci. Chem Rev. 2010;111(1):117-51. doi: 10.1021/cr100370n PMID: 21174435
15. Zhu J, Kaufmann GF. Quo vadis quorum quenching? Curr Opin Pharmacol. 2013;13(5):688-98. doi: 10.1016/j.coph.2013.07.003 PMID: 23876839
16. Quave CL, Horswill AR. Flipping the switch: Tools for detecting small molecule inhibitors of staphylococcal virulence. Frontiers in Microbiology. 2014;5. doi: 10.3389/fmicb.2014.00706
17. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008;168(14):1585-91. doi: 10.1001/archinte.168.14.1585 PMID: 18663172
18. Daum RS. Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med. 2007;357(4):380-90. PMID: 17652653
19. Stryjewski ME, Chambers HF. Skin and soft-tissue infections caused by community-acquired methicillinresistant Staphylococcus aureus. Clin Infect Dis. 2008;46 Suppl 5:S368-77. doi: 10.1086/533593 PMID: 18462092
20. Wright JS 3rd, Jin R, Novick RP. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci USA. 2005;102(5):1691-6. PMID: 15665088
21. Park J, Jagasia R, Kaufmann GF, Mathison JC, Ruiz DI, Moss JA, et al. Infection control by antibody disruption of bacterial quorum sensing signaling. Chem Biol. 2007;14(10):1119-27. PMID: 17961824
22. Schwan WR, Langhorne MH, Ritchie HD, Stover CK. Loss of hemolysin expression in Staphylococcus aureus agr mutants correlates with selective survival during mixed infections in murine abscesses and wounds. FEMS Immunol Med Microbiol. 2003;38(1):23-8. PMID: 12900051
23. Mayville P, Ji G, Beavis R, Yang H, Goger M, Novick RP, et al. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc Natl Acad Sci USA. 1999;96(4):1218-23. PMID: 9990004
24. Wright JD, Holland KT. The effect of cell density and specific growth rate on accessory gene regulator and toxic shock syndrome toxin-1 gene expression in Staphylococcus aureus. FEMS Microbiol Lett. 2003;218:377-83. PMID: 12586420
25. Kennedy AD, Wardenburg JB, Gardner DJ, Long D, Whitney AR, Braughton KR, et al. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis. 2010;202(7):1050-8. doi: 10.1086/656043 PMID: 20726702
26. Heyer G, Saba S, Adamo R, Rush W, Soong G, Cheung A, et al. Staphylococcus aureus agr and sarA functions are required for invasive infection but not inflammatory responses in the lung. Infect Immun. 2002;70(1):127-33. PMID: 11748173
27. Bubeck Wardenburg J, Patel RJ, Schneewind O. Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun. 2007;75(2):1040-4. PMID: 17101657
28. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med. 2007;13(12):1405-6. PMID: 18064027
29. Montgomery CP, Boyle-Vavra S, Daum RS. Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS One. 2010;5(12):e15177. doi: 10.1371/journal. pone.0015177 PMID: 21151999
30. Kennedy AD, Otto M, Braughton KR, Whitney AR, Chen L, Mathema B, et al. Epidemic communityassociated methicillin-resistant Staphylococcus aureus: Recent clonal expansion and diversification. Proc Natl Acad Sci USA. 2008;105(4):1327-32. doi: 10.1073/pnas.0710217105 PMID: 18216255
31. Gordon CP, Williams P, Chan WC. Attenuating Staphylococcus aureus virulence gene regulation: a medicinal chemistry perspective. J Med Chem. 2013;56(4):1389-404. doi: 10.1021/jm3014635 PMID: 23294220
32. Geisinger E, George EA, Muir TW, Novick RP. Identification of ligand specificity determinants in AgrC, the Staphylococcus aureus quorum-sensing receptor. J Biol Chem. 2008;283(14):8930-8. doi: 10. 1074/jbc. M710227200 PMID: 18222919
33. Geisinger E, Muir TW, Novick RP. Agr receptor mutants reveal distinct modes of inhibition by staphylococcal autoinducing peptides. Proc Natl Acad Sci USA. 2009;106(4):1216-21. doi: 10.1073/pnas. 0807760106 PMID: 19147840
34. Mayville P, Ji G, Beavis R, Yang H, Goger M, Novick RP, et al. Structure-activity analysis of synthetic autoinducing thiolactone peptides from Staphylococcus aureus responsible for virulence. Proc Natl Acad Sci USA. 1999;96:1218-23. PMID: 9990004
35. Sully EK, Malachowa N, Elmore BO, Alexander SM, Femling JK, Gray BM, et al. Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance. PLoS Pathogens. 2014;10(6):e1004174. doi: 10.1371/journal.ppat.1004174 PMID: 24945495
36. Figueroa M, Jarmusch AK, Raja HA, El-Elimat T, Kavanaugh JS, Horswill AR, et al. Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by Desorption Electrospray Ionization Mass Spectrometry. J Nat Prod. 2014;77(6):1351-8. doi: 10.1021/np5000704 PMID: 24911880
37. Daly SM, Elmore BO, Kavanaugh JS, Triplett KD, Figueroa M, Raja HA, et al. ω-Hydroxyemodin limits Staphylococcus aureus quorum sensing-mediated pathogenesis and inflammation. Antimicrob Agents Chemother. 2015;59(4):2223-35. doi: 10.1128/aac.04564-14 PMID: 25645827
38. Nielsen A, Mansson M, Bojer MS, Gram L, Larsen TO, Novick RP, et al. Solonamide B inhibits quorum sensing and reduces Staphylococcus aureus mediated killing of human neutrophils. PLoS One. 2014;9(1):e84992. doi: 10.1371/journal.pone.0084992 PMID: 24416329
39. Nakayama J, Uemura Y, Nishiguchi K, Yoshimura N, Igarashi Y, Sonomoto K. Ambuic acid inhibits the biosynthesis of cyclic peptide quormones in Gram-Positive bacteria. Antimicrob Agents Chemother. 2009;53(2):580-6. doi: 10.1128/aac.00995-08 PMID: 19015326
40. WHO. World Health Organization guidelines on good agricultural and collection practices (GACP) for medicinal plants.. Geneva, Switzerland: WHO; 2003.
41. Pignatti S. Flora d'Italia. Bologna, Italy: Edizioni Edagricole; 2002.
42. Almeida I, Costa P, Bahia MF. Evaluation of functional stability and batch-to-batch reproducibility of a Castanea sativa leaf extract with antioxidant activity. AAPS PharmSciTech. 2010;11(1):120-5. doi: 10. 1208/s12249-009-9360-9 PMID: 20066522
43. Malik A, Yuldashev MP, Obid A, Ismoil T, Ping LY. Flavonoids of the aerial part of Lycopus lucidus. Chem Nat Cmpd. 2002;38(6):612-3. doi: 10.1023/A:1022667611501
44. M100-S23. Performance standards for antimicrobial testing; 23rd informational supplement: Clinical and Laboratory Standards Institute; 2013.
45. M45-A2. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; Approved guideline-2nd Edition: Clinical and Laboratory Standards Institute; 2010.
46. Tsai T-H, Tsai T-H, Wu W-H, Tseng JT-P, Tsai P-J. In vitro antimicrobial and anti-inflammatory effects of herbs against Propionibacterium acnes. Food Chem. 2010;119(3):964-8. doi: 10.1016/j.foodchem. 2009.07.062
47. Kirchdoerfer RN, Garner AL, Flack CE, Mee JM, Horswill AR, Janda KD, et al. Structural basis for ligand recognition and discrimination of a quorum-quenching antibody. J Biol Chem. 2011;286(19):17351-8. doi: 10.1074/jbc. M111.231258 PMID: 21454495
48. Boles B, Thoendel M, Roth A, Horswill A. Identification of genes involved in polysaccharide-independent Staphylococcus aureus biofilm formation. PLoS One. 2010;5(e10146). doi: 10.1371/journal.pone. 0010146
49. Olson ME, Nygaard TK, Ackermann L, Watkins RL, Zurek OW, Pallister KB, et al. Staphylococcus aureus nuclease is an SaeRS-dependent virulence factor. Infect Immun. 2013;81(4):1316-24. doi: 10. 1128/IAI.01242-12 PMID: 23381999
50. Otto M, Gotz F. Analysis of quorum sensing activity in staphylococci by RP-HPLC of staphylococcal delta-toxin. Biotechniques. 2000;28(6):1088-96. PMID: 10868273
51. Somerville GA, Cockayne A, Durr M, Peschel A, Otto M, Musser JM. Synthesis and deformylation of Staphylococcus aureus δ-toxin are linked to tricarboxylic acid cycle activity. J Bacteriol. 2003;185(22):6686-94. PMID: 14594843
52. Beenken KE, Blevins JS, Smeltzer MS. Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect Immun. 2003;71(7):4206-11. PMID: 12819120
53. Gillaspy A, Hickmon S, Skinner R, Thomas J, Nelson C, Smeltzer M. Role of the accessory gene regulator (agr) in pathogenesis of staphylococcal osteomyelitis. Infect Immun. 1995;63(9):3373-80. PMID: 7642265
54. Talekar SJ, Chochua S, Nelson K, Klugman KP, Quave CL, Vidal JE. 220D-F2 from Rubus ulmifolius kills Streptococcus pneumoniae planktonic cells and pneumococcal biofilms. PLoS One. 2014;9(5):e97314. doi: 10.1371/journal.pone.0097314 PMID: 24823499
55. Cox P, Balick M. The ethnobotanical approach to drug discovery. Sci Am. 1994;270(1):82-7.
56. Almeida IF, Fernandes E, Lima JLFC, Costa PC, Bahia MF. Protective effect of Castanea sativa and Quercus robur leaf extracts against oxygen and nitrogen reactive species. J Photochem Photobiol B. 2008;91(2-3):87-95. doi: 10.1016/j.jphotobiol.2008.02.001 PMID: 18337113
57. Almeida IF, Pinto AS, Monteiro C, Monteiro H, Belo L, Fernandes J, et al. Protective effect of C. sativa leaf extract against UV mediated-DNA damage in a human keratinocyte cell line. J Photochem Photobiol B. 2015;144(0):28-34. doi: 10.1016/j.jphotobiol.2015.01.010
58. Almeida IF, Valentao P, Andrade PB, Seabra RM, Pereira TM, Amaral MH, et al. In vivo skin irritation potential of a Castanea sativa (Chestnut) leaf extract, a putative natural antioxidant for topical application. Basic Clin Pharmacol. 2008;103(5):461-7. doi: 10.1111/j.1742-7843.2008.00301.x
59. Henry F, Danoux L, Pauly G, inventors; Cognis France S. A. S., Boussens (FR), assignee. Cosmetic compositions containing an extract of leaves of the Castanea sativa plant and cosmetic treatments USA 2011.
60. Grice E, Kong H, Conlan S, Deming C, Davis J, Young A, et al. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324(5931):1190-2. doi: 10.1126/science.1171700 PMID: 19478181
61. Muszer M, Noszczyíska M, Kasperkiewicz K, Skurnik M. Human microbiome: When a friend becomes an enemy. Arch Immunol Ther Exp. 2015:1-12. doi: 10.1007/s00005-015-0332-3
62. Naik S, Bouladoux N, Linehan JL, Han S-J, Harrison OJ, Wilhelm C, et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature. 2015;520(7545):104-8. doi: 10.1038/nature14052 PMID: 25539086
63. Elfawal MA, Towler MJ, Reich NG, Weathers PJ, Rich SM. Dried whole-plant Artemisia annua slows evolution of malaria drug resistance and overcomes resistance to artemisinin. Proc Natl Acad Sci USA. 2015;112(3):821-6. doi: 10.1073/pnas.1413127112 PMID: 25561559
64. Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol. 2007;3(7):360-6. doi: 10.1038/nchembio0707-360 PMID: 17576417
65. Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. Embo J. 1993;12(10):3967-75. PMID: 7691599
66. Parker D, Narechania A, Sebra R, Deikus G, La Russa S, Ryan C, et al. Genome sequence of bacterial interference strain Staphylococcus aureus 502A. Genome Announc. 2014;2 (2). doi: 10.1128/genomeA.00284-14
67. Ibberson CB, Jones CL, Singh S, Wise MC, Hart ME, Zurawski DV, et al. Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor. Infect Immun. 2014;82(10):4253-64. doi: 10.1128/iai. 01710-14 PMID: 25069977
68. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K-I, Oguchi A, et al. Genome and virulence determinants of high virulence community-acquired MRSA. The Lancet. 2002;359(9320):1819-27. doi: 10. 1016/S0140-6736 (02) 08713-5
69. McDougal LK, Steward CD, Killgore GE, Chaitram JM, McAllister SK, Tenover FC. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: Establishing a national database. J Clin Microbiol. 2003;41(11):5113-20. PMID: 14605147